{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:42:42Z","timestamp":1790304162120,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","immunology.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.iac.2017.03.002","type":"journal-article","created":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T13:47:08Z","timestamp":1494856028000},"page":"497-511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Acquired C1 Inhibitor Deficiency"],"prefix":"10.1016","volume":"37","author":[{"given":"Iris M.","family":"Otani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleena","family":"Banerji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.iac.2017.03.002_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0090-1229(72)90006-2","article-title":"Acquired C1 inhibitor deficiency in lymphosarcoma","volume":"1","author":"Caldwell","year":"1972","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.iac.2017.03.002_bib2","unstructured":"Cicardi M. Acquired C1 inhibitor deficiency: clinical manifestations, epidemiology, pathogenesis, and diagnosis - UpToDate. Available at: https:\/\/www.uptodate.com\/contents\/acquired-c1-inhibitor-deficiency-clinical-manifestations-epidemiology-pathogenesis-and-diagnosis?source=search_result&search=acquiredangioedema&selectedTitle=1\u223c32. Accessed December 4, 2016."},{"issue":"5","key":"10.1016\/j.iac.2017.03.002_bib3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/joim.12304","article-title":"Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients","volume":"277","author":"Mansi","year":"2015","journal-title":"J\u00a0Intern Med"},{"issue":"9","key":"10.1016\/j.iac.2017.03.002_bib4","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1503\/cmaj.060535","article-title":"Angioedema without urticaria: a large clinical survey","volume":"175","author":"Zingale","year":"2006","journal-title":"CMAJ"},{"issue":"5","key":"10.1016\/j.iac.2017.03.002_bib5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2500\/aap.2010.31.3361","article-title":"Acquired angioedema: autoantibody associations and C1q utility as a diagnostic tool","volume":"31","author":"Breitbart","year":"2010","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"10.1016\/j.iac.2017.03.002_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/cei.12159","article-title":"A\u00a0UK national audit of hereditary and acquired angioedema","volume":"175","author":"Jolles","year":"2014","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.iac.2017.03.002_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000351452","article-title":"Acquired angioedema\u2013occurrence, clinical features and associated disorders in a Danish nationwide patient cohort","volume":"162","author":"Bygum","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"issue":"4","key":"10.1016\/j.iac.2017.03.002_bib8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000336590","article-title":"Hereditary and acquired complement component 1 esterase inhibitor deficiency: a review for the hematologist","volume":"127","author":"Cicardi","year":"2012","journal-title":"Acta Haematol"},{"issue":"33","key":"10.1016\/j.iac.2017.03.002_bib9","doi-asserted-by":"crossref","first-page":"e4363","DOI":"10.1097\/MD.0000000000004363","article-title":"A\u00a0nationwide study of acquired C1-inhibitor deficiency in France","volume":"95","author":"Gobert","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.iac.2017.03.002_bib10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2174\/156652410791317066","article-title":"The acquired deficiency of C1-inhibitor: lymphoproliferation and angioedema","volume":"10","author":"Cicardi","year":"2010","journal-title":"Curr Mol Med"},{"issue":"3","key":"10.1016\/j.iac.2017.03.002_bib11","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.jaci.2004.06.047","article-title":"Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond","volume":"114","author":"Agostoni","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2017.03.002_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.anai.2012.10.008","article-title":"International consensus on hereditary and acquired angioedema","volume":"109","author":"Lang","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.iac.2017.03.002_bib13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0002-9343(03)00396-6","article-title":"Clinical and biological distinctions between type I and type II acquired angioedema","volume":"115","author":"Bouillet-Claveyrolas","year":"2003","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.iac.2017.03.002_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/0310057X0303100120","article-title":"Angioedema of the tongue due to acquired C1 esterase inhibitor deficiency","volume":"31","author":"Dobson","year":"2003","journal-title":"Anaesth Intensive Care"},{"issue":"3","key":"10.1016\/j.iac.2017.03.002_bib15","first-page":"436","article-title":"Angioedema presenting as chronic gastrointestinal symptoms","volume":"88","author":"Eck","year":"1993","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.iac.2017.03.002_bib16","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/ACI.0000000000000082","article-title":"An evidence based therapeutic approach to hereditary and acquired angioedema","volume":"14","author":"Bork","year":"2014","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2017.03.002_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1515\/cclm-2015-0195","article-title":"The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity","volume":"54","author":"Wu","year":"2016","journal-title":"Clin Chem Lab Med"},{"issue":"5031","key":"10.1016\/j.iac.2017.03.002_bib18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/210098a0","article-title":"Separation of 2 different substrates for plasma kinin-forming enzymes","volume":"210","author":"Jacobsen","year":"1966","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.iac.2017.03.002_bib19","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1046\/j.1440-1681.2001.03564.x","article-title":"The kallikrein-kinin system in humans","volume":"28","author":"Campbell","year":"2001","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"4","key":"10.1016\/j.iac.2017.03.002_bib20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/07853890.2016.1162909","article-title":"Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment","volume":"48","author":"Zeerleder","year":"2016","journal-title":"Ann Med"},{"issue":"2","key":"10.1016\/j.iac.2017.03.002_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000368404","article-title":"Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting","volume":"165","author":"Craig","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"issue":"22","key":"10.1016\/j.iac.2017.03.002_bib22","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1056\/NEJM198705283162202","article-title":"Autoantibody-mediated acquired deficiency of C1 inhibitor","volume":"316","author":"Alsenz","year":"1987","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.iac.2017.03.002_bib23","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V48.4.567.567","article-title":"Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality","volume":"48","author":"Schreiber","year":"1976","journal-title":"Blood"},{"issue":"814","key":"10.1016\/j.iac.2017.03.002_bib24","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/pgmj.69.814.646","article-title":"Acquired C1 inhibitor deficiency with lymphoma causing recurrent angioedema","volume":"69","author":"Mathur","year":"1993","journal-title":"Postgrad Med J"},{"issue":"5","key":"10.1016\/j.iac.2017.03.002_bib25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-87-5-577","article-title":"Treatment of acquired C1-inhibitor deficiency with danazol","volume":"87","author":"Hauptmann","year":"1977","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.iac.2017.03.002_bib26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF00995913","article-title":"Acquired c1-inhibitor deficiencies in lymphoproliferative diseases with serum immunoglobulin abnormalities. A study of three cases","volume":"32","author":"Hauptmann","year":"1976","journal-title":"Blut"},{"issue":"2","key":"10.1016\/j.iac.2017.03.002_bib27","first-page":"189","article-title":"Evidence for immune complexes involving anti-lymphocyte antibodies associated with hypocomplementaemia in chronic lymphocytic leukaemia (CLL)","volume":"26","author":"Day","year":"1976","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.iac.2017.03.002_bib28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-88-3-429_1","article-title":"Danazol and C1 esterase inhibitor deficiency","volume":"88","author":"Cohen","year":"1978","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.iac.2017.03.002_bib29","first-page":"523","article-title":"Acquired C1 inhibitor deficiency in a case of lymphosarcoma of the spleen. Reversal of complement abnormalities after splenectomy","volume":"37","author":"Hauptmann","year":"1979","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.iac.2017.03.002_bib30","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJM198502283120902","article-title":"Acquired C1-inhibitor deficiency associated with antiidiotypic antibody to monoclonal immunoglobulins","volume":"312","author":"Geha","year":"1985","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iac.2017.03.002_bib31","first-page":"264","article-title":"An IgG autoantibody which inactivates C1-inhibitor","volume":"320","author":"Jackson","year":"1986","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.iac.2017.03.002_bib32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2249.1996.d01-866.x","article-title":"Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angio-oedema","volume":"106","author":"Cicardi","year":"1996","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"10.1016\/j.iac.2017.03.002_bib33","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/1529-0131(200108)44:8<1836::AID-ART321>3.0.CO;2-Y","article-title":"A\u00a0new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus","volume":"44","author":"Cacoub","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.iac.2017.03.002_bib34","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1365-2249.1993.tb03391.x","article-title":"C1 inhibitor functional deficiency in systemic lupus erythematosus (SLE)","volume":"92","author":"Jazwinska","year":"1993","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"10.1016\/j.iac.2017.03.002_bib35","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/ard.50.10.713","article-title":"Acquired C 1 inhibitor deficiency associated with systemic lupus erythematosus affecting the central nervous system","volume":"50","author":"Nakamura","year":"1991","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.iac.2017.03.002_bib36","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1365-2362.2005.01571.x","article-title":"Acquired C1-inhibitor deficiency in a patient with systemic lupus erythematosus: a case report and review of the literature","volume":"35","author":"Nettis","year":"2005","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"10.1016\/j.iac.2017.03.002_bib37","first-page":"627","article-title":"Acquired C1-esterase inhibitor deficiency and positive lupus anticoagulant accompanied by splenic marginal zone B-cell lymphoma","volume":"25","author":"Sugisaki","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.iac.2017.03.002_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-016-8539-6","article-title":"\u201cNuts and bolts\u201d of laboratory evaluation of angioedema","volume":"51","author":"Farkas","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1016\/j.iac.2017.03.002_bib39","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.iac.2015.01.004","article-title":"Idiopathic anaphylaxis","volume":"35","author":"Fenny","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"issue":"5","key":"10.1016\/j.iac.2017.03.002_bib40","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.jaci.2014.02.036","article-title":"The diagnosis and management of acute and chronic urticaria: 2014 update","volume":"133","author":"Bernstein","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2017.03.002_bib41","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.12688\/f1000research.9565.1","article-title":"Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes","volume":"5","author":"Gonz\u00e1lez-de-Olano","year":"2016","journal-title":"F1000Research"},{"issue":"1","key":"10.1016\/j.iac.2017.03.002_bib42","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jaci.2016.04.029","article-title":"Trends, characteristics, and incidence of anaphylaxis in 2001-2010: a population-based study","volume":"139","author":"Lee","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2017.03.002_bib43","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jaci.2011.01.025","article-title":"Stinging insect hypersensitivity: a practice parameter update 2011","volume":"127","author":"Golden","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2017.03.002_bib44","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.iac.2016.08.013","article-title":"Cutaneous manifestation of food allergy","volume":"37","author":"Tam","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"issue":"5","key":"10.1016\/j.iac.2017.03.002_bib45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11894-015-0440-6","article-title":"Palliative care for patients with end-stage liver disease","volume":"17","author":"Larson","year":"2015","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.iac.2017.03.002_bib46","first-page":"1","article-title":"Symptom burden in heart failure: assessment, impact on outcomes, and management","volume":"22","author":"Alpert","year":"2016","journal-title":"Heart Fail Rev"},{"issue":"1","key":"10.1016\/j.iac.2017.03.002_bib47","first-page":"015","article-title":"The genetics of nephrotic syndrome","volume":"5","author":"Rheault","year":"2015","journal-title":"J\u00a0Pediatr Genet"},{"issue":"3","key":"10.1016\/j.iac.2017.03.002_bib48","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3324\/haematol.2013.091264","article-title":"Episodic angioedema with eosinophilia (Gleich syndrome) is a multilineage cell cycling disorder","volume":"100","author":"Khoury","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.iac.2017.03.002_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-217428","article-title":"Non-episodic angioedema associated with eosinophilia","volume":"2016","author":"Shikino","year":"2016","journal-title":"BMJ Case Rep"},{"issue":"8","key":"10.1016\/j.iac.2017.03.002_bib50","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/petr.12831","article-title":"Epidemiology, risk factors, and prognosis of capillary leak syndrome in pediatric recipients of stem cell transplants: a retrospective single-center cohort study","volume":"20","author":"Lucchini","year":"2016","journal-title":"Pediatr Transplant"},{"issue":"2","key":"10.1016\/j.iac.2017.03.002_bib51","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jaip.2016.09.034","article-title":"Melkersson-Rosenthal syndrome","volume":"5","author":"Singh Bakshi","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.iac.2017.03.002_bib52","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jaci.2012.05.017","article-title":"A\u00a0mechanism for urticaria\/angioedema in patients with thyroid disease","volume":"130","author":"Kirkpatrick","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2017.03.002_bib53","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2500\/aap.2015.36.3883","article-title":"Association between thyroid autoimmunity and recurrent angioedema in children","volume":"36","author":"Karagol","year":"2015","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"10.1016\/j.iac.2017.03.002_bib54","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2500\/aap.2015.36.3800","article-title":"Management of patients with nonaspirin-exacerbated respiratory disease aspirin hypersensitivity reactions","volume":"36","author":"Saff","year":"2015","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.iac.2017.03.002_bib55","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000358619","article-title":"Bradykinin-mediated diseases","volume":"100","author":"Kaplan","year":"2014","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.iac.2017.03.002_bib56","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jaip.2013.07.005","article-title":"ACE inhibitor\u2013induced angioedema","volume":"1","author":"Baram","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.iac.2017.03.002_bib57","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1710-1492-6-14","article-title":"Acquired angioedema","volume":"6","author":"Cicardi","year":"2010","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2017.03.002_bib58","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/all.12380","article-title":"Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group","volume":"69","author":"Cicardi","year":"2014","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.iac.2017.03.002_bib59","first-page":"381","article-title":"C1 inhibitor deficiency: molecular and immunologic basis of hereditary and acquired angioedema","volume":"65","author":"Oltvai","year":"2016","journal-title":"Lab Investig A J Tech Methods Pathol"},{"issue":"5","key":"10.1016\/j.iac.2017.03.002_bib60","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s10875-012-9691-2","article-title":"Acquired C1-inhibitor deficiency: 7 patients treated with rituximab","volume":"32","author":"Branellec","year":"2012","journal-title":"J\u00a0Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2017.03.002_bib61","first-page":"315","article-title":"Successful rituximab B lymphocyte depletion therapy for angioedema due to acquired C1 inhibitor protein deficiency: association with reduced C1 inhibitor protein autoantibody titers","volume":"16","author":"Dreyfus","year":"2014","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.iac.2017.03.002_bib62","first-page":"165","article-title":"Rituximab therapy in a patient with low grade B-cell lymphoproliferative disease and concomitant acquired angioedema","volume":"7","author":"Kaur","year":"2014","journal-title":"J\u00a0Asthma Allergy"},{"issue":"1","key":"10.1016\/j.iac.2017.03.002_bib63","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1710-1492-6-24","article-title":"2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy","volume":"6","author":"Bowen","year":"2010","journal-title":"Asthma Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2017.03.002_bib64","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2500\/aap.2013.34.3620","article-title":"Ecallantide for treatment of acute attacks of acquired C1 esterase inhibitor deficiency","volume":"34","author":"Patel","year":"2013","journal-title":"Allergy Asthma Proc"},{"issue":"8","key":"10.1016\/j.iac.2017.03.002_bib65","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1398-9995.2012.02853.x","article-title":"Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study","volume":"67","author":"Zanichelli","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2017.03.002_bib66","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jclinane.2016.05.010","article-title":"Perioperative course in patients with hereditary or acquired angioedema","volume":"34","author":"MacBeth","year":"2016","journal-title":"J\u00a0Clin Anesth"},{"issue":"5","key":"10.1016\/j.iac.2017.03.002_bib67","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/0091-6749(94)90380-8","article-title":"Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid","volume":"93","author":"Cugno","year":"1994","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2017.03.002_bib68","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1398-9995.2009.02234.x","article-title":"Efficacy of tranexamic acid in sporadic idiopathic bradykinin angioedema","volume":"65","author":"Du-Thanh","year":"2009","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.iac.2017.03.002_bib69","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0002-9343(99)00123-0","article-title":"Idiopathic nonhistaminergic angioedema","volume":"106","author":"Cicardi","year":"1999","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.iac.2017.03.002_bib70","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1081-1206(10)60886-1","article-title":"Fresh frozen plasma for the treatment of hereditary angioedema.","volume":"98","author":"Prematta","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"16","key":"10.1016\/j.iac.2017.03.002_bib71","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1200\/JCO.2011.38.9957","article-title":"Acquired angioedema and marginal zone lymphoma","volume":"30","author":"Lam","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.iac.2017.03.002_bib72","first-page":"ELT13","article-title":"Acquired angioedema: a new target for rituximab?","volume":"89","author":"Ziakas","year":"2004","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.iac.2017.03.002_bib73","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.amjmed.2005.09.018","article-title":"Rituximab-induced elimination of acquired angioedema due to C1-inhibitor deficiency","volume":"119","author":"Levi","year":"2006","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.iac.2017.03.002_bib74","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2340\/00015555-1157","article-title":"Acquired angioedema responding to rituximab","volume":"91","author":"Hassan","year":"2011","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.iac.2017.03.002_bib75","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/0961203307087405","article-title":"Successful use of rituximab in acquired C1 inhibitor deficiency secondary to Sjogren\u2019s syndrome","volume":"17","author":"Sanchez-Cano","year":"2008","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.iac.2017.03.002_bib76","first-page":"143","article-title":"Anaplastic large cell lymphoma and acquired angioedema: a novel association?","volume":"17","author":"Rossi","year":"2002","journal-title":"Ann Ital Med Int"},{"issue":"5","key":"10.1016\/j.iac.2017.03.002_bib77","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.tripleo.2006.11.015","article-title":"Acquired angioedema in non-Hodgkin\u2019s lymphoma","volume":"103","author":"Healy","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"2","key":"10.1016\/j.iac.2017.03.002_bib78","first-page":"126","article-title":"Acquired angioedema associated with hereditary angioedema due to C1 inhibitor deficiency","volume":"18","author":"Guilarte","year":"2008","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.iac.2017.03.002_bib79","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.clml.2011.02.005","article-title":"Unusual autoimmune nonhematologic complications in chronic lymphocytic leukemia","volume":"11","author":"Jung","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"5","key":"10.1016\/j.iac.2017.03.002_bib80","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3324\/haematol.10769","article-title":"Lymphoproliferative disease and acquired C1 inhibitor deficiency","volume":"92","author":"Castelli","year":"2007","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.iac.2017.03.002_bib81","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.critrevonc.2013.02.004","article-title":"Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship","volume":"87","author":"Castelli","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"10.1016\/j.iac.2017.03.002_bib82","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/01.md.0000085055.63483.09","article-title":"Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies","volume":"82","author":"Cicardi","year":"2003","journal-title":"Medicine (Baltimore)"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856117300309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856117300309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T16:09:46Z","timestamp":1750262986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856117300309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0889856117300309"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2017.03.002","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired C1 Inhibitor Deficiency","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2017.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}